{"id":"oral-ketamine","safety":{"commonSideEffects":[{"rate":null,"effect":"Dissociation"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Increased blood pressure"},{"rate":null,"effect":"Sedation"},{"rate":null,"effect":"Hallucinations"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ketamine binds to the phencyclidine binding site within the NMDA receptor ion channel, blocking the flow of ions and preventing excitatory neurotransmission. This mechanism produces rapid-onset anesthetic, analgesic, and dissociative effects. At sub-anesthetic doses, ketamine has demonstrated rapid-acting antidepressant properties, likely through effects on glutamatergic neurotransmission and downstream neuroplasticity pathways.","oneSentence":"Ketamine is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor that blocks glutamate signaling in the central nervous system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:46.791Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment-resistant depression (off-label/emerging indication)"},{"name":"Chronic pain conditions (off-label)"},{"name":"Anesthesia induction and maintenance"}]},"trialDetails":[{"nctId":"NCT06464146","phase":"PHASE3","title":"Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine vs Oral Morphine","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-02-26","conditions":"Limb Injury","enrollment":300},{"nctId":"NCT06867068","phase":"PHASE1","title":"Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2016-10-04","conditions":"Anesthesia, Tooth Extraction","enrollment":73},{"nctId":"NCT06340958","phase":"PHASE2","title":"A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder","status":"COMPLETED","sponsor":"Clexio Biosciences Ltd.","startDate":"2024-03-18","conditions":"Adjunctive Treatment of Major Depressive Disorder (MDD)","enrollment":99},{"nctId":"NCT07396272","phase":"PHASE2","title":"A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression","status":"RECRUITING","sponsor":"Daniel Lindqvist","startDate":"2026-04-01","conditions":"Major Depressive Disorder (MDD)","enrollment":12},{"nctId":"NCT07227454","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2026-01-08","conditions":"Depressive Disorder, Major","enrollment":258},{"nctId":"NCT07284667","phase":"PHASE2","title":"ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response","status":"RECRUITING","sponsor":"ACADIA Pharmaceuticals Inc.","startDate":"2025-11-14","conditions":"Major Depressive Disorder (MDD), Depressive Disorder, Treatment-Resistant","enrollment":153},{"nctId":"NCT07461376","phase":"NA","title":"Premedication in Children: a Clinical Trial Comparing Oral Ketamine and Oral Clonidine With Respect to Sedation Level and Opioid Consumption in Pediatrics Undergoing Elective Lower Abdominal Day-case Surgery.","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-04-15","conditions":"Pediatric Sedation, Clonidine Sedation, Ketamine Sedation","enrollment":84},{"nctId":"NCT07462559","phase":"PHASE1","title":"KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-03-04","conditions":"Drug Drug Interaction","enrollment":12},{"nctId":"NCT07450430","phase":"PHASE3","title":"Optimal Timing of Ketamine Initiation for SCD Pain","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-02","conditions":"Sickle Cell Disease, Sickle Cell Crisis","enrollment":90},{"nctId":"NCT05597878","phase":"PHASE2, PHASE3","title":"Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy","status":"SUSPENDED","sponsor":"Wake Forest University Health Sciences","startDate":"2023-04-18","conditions":"Pain Management, Opioid Use, Prostate Cancer","enrollment":100},{"nctId":"NCT07410078","phase":"NA","title":"Comparative Assessment of Oral Premedication Regimens in Pediatric Ambulatory Surgery","status":"NOT_YET_RECRUITING","sponsor":"Diskapi Yildirim Beyazit Education and Research Hospital","startDate":"2026-02-19","conditions":"Pediatric Anesthesia, Premedication","enrollment":135},{"nctId":"NCT06772753","phase":"PHASE1","title":"Investigation of Psychedelic Effects in Psychoactive Substances","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-02-05","conditions":"Psychedelic Effects in Healthy Volunteers","enrollment":50},{"nctId":"NCT06419985","phase":"PHASE2","title":"Ketamine HCl Prolonged Release Oral Tablets for CRPS","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2026-07","conditions":"Complex Regional Pain Syndromes","enrollment":65},{"nctId":"NCT06879496","phase":"NA","title":"Comparison of Oral Dexmedetomidine, Ketamine Versus Midazolam for Premedication in Children Undergoing Injuinal Surgeries","status":"COMPLETED","sponsor":"Tanta University","startDate":"2025-03-10","conditions":"Pediatric, Anesthesia","enrollment":60},{"nctId":"NCT05086250","phase":"EARLY_PHASE1","title":"Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-10-20","conditions":"Anxiety, Pancreatic Cancer","enrollment":20},{"nctId":"NCT07317232","phase":"NA","title":"Ayahuasca, Esketamine and Premenstrual Symptoms","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-12-20","conditions":"Healthy Women Volunteers","enrollment":20},{"nctId":"NCT07317206","phase":"PHASE2","title":"Ayahuasca, Esketamine and PTSD","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-12-20","conditions":"Posttraumatic Stress Disorder (PTSD)","enrollment":10},{"nctId":"NCT07317219","phase":"NA","title":"Ayahuasca, Esketamine and Body Image Perception","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-12-20","conditions":"Healthy Women Volunteers","enrollment":20},{"nctId":"NCT07212946","phase":"PHASE2","title":"Ayahuasca and Esketamine for Major Depression","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2022-10-30","conditions":"Major Depression Severe","enrollment":22},{"nctId":"NCT05279898","phase":"NA","title":"Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2023-02-28","conditions":"Postoperative Delirium, Hemodynamic Instability, Pain","enrollment":70},{"nctId":"NCT05403086","phase":"PHASE2","title":"Pragmatic Trial of Psilocybin Therapy in Palliative Care","status":"RECRUITING","sponsor":"Charles S. Grob, M.D.","startDate":"2025-01-19","conditions":"Demoralization","enrollment":100},{"nctId":"NCT05378555","phase":"PHASE3","title":"Oral Ketamine for Treatment of Vaso-Occlusive Pain","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2023-05-01","conditions":"Vaso-occlusive Crisis","enrollment":10},{"nctId":"NCT05421065","phase":"PHASE2","title":"Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peggy C Nopoulos","startDate":"2024-02-02","conditions":"Alcohol Use Disorder","enrollment":20},{"nctId":"NCT04103892","phase":"PHASE2","title":"A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study","status":"COMPLETED","sponsor":"Clexio Biosciences Ltd.","startDate":"2019-09-05","conditions":"Adjunctive Treatment of Major Depressive Disorder","enrollment":146},{"nctId":"NCT05049343","phase":"PHASE1","title":"Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants","status":"COMPLETED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2021-09-21","conditions":"Healthy Volunteer","enrollment":22},{"nctId":"NCT07153406","phase":"PHASE3","title":"Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients","status":"NOT_YET_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2025-09-15","conditions":"Depressive Disorder","enrollment":220},{"nctId":"NCT07112456","phase":"PHASE2","title":"Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations","status":"NOT_YET_RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2026-09-01","conditions":"Asthma Acute, Asthma Attack, Asthma Exacerbations","enrollment":100},{"nctId":"NCT05756621","phase":"","title":"Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2022-01-15","conditions":"Status Epilepticus, Cardiac Arrest","enrollment":80},{"nctId":"NCT07074262","phase":"NA","title":"Comparison Between the Effect of Dexmedetomidine _midazolam and ketamine_midazolam Combination","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-10-10","conditions":"Postoperative Cognitive Dysfunction, Post Operative Delirium","enrollment":114},{"nctId":"NCT03794362","phase":"","title":"Measuring Analgesic Interventions","status":"RECRUITING","sponsor":"Julia Finkel","startDate":"2018-10-29","conditions":"Pain","enrollment":120},{"nctId":"NCT04413799","phase":"EARLY_PHASE1","title":"PVB vs Ketamine/Lidocaine in Rib Fracture Patients","status":"TERMINATED","sponsor":"George Washington University","startDate":"2020-09-01","conditions":"Rib Fractures, Rib Trauma, Rib Fracture Multiple","enrollment":32},{"nctId":"NCT06968624","phase":"PHASE4","title":"Ketamine for Postherpetic Neuralgia With Depression","status":"NOT_YET_RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2025-06-15","conditions":"Depression Disorders, Herpetic Neuralgia","enrollment":50},{"nctId":"NCT06989567","phase":"PHASE3","title":"A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis","status":"NOT_YET_RECRUITING","sponsor":"Asklepion Pharmaceuticals, LLC","startDate":"2025-07-25","conditions":"Sickle Cell Disease","enrollment":120},{"nctId":"NCT06077487","phase":"PHASE4","title":"Ketamine-assisted Therapy for Advanced GI Cancer","status":"TERMINATED","sponsor":"Brian Anderson, MD","startDate":"2024-05-17","conditions":"Pancreatic Ductal Adenocarcinoma, Pain, Acute, Gastrointestinal Cancers","enrollment":1},{"nctId":"NCT06898463","phase":"PHASE4","title":"Comparison Of The Effects Of Melatonin Premedication And Ketamine On Postoperative Sleep Quality İn Rhinoplasty","status":"COMPLETED","sponsor":"Konya City Hospital","startDate":"2022-09-19","conditions":"Postoperative Sleep Disturbances","enrollment":183},{"nctId":"NCT02417064","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-10","conditions":"Treatment-resistant Depression","enrollment":346},{"nctId":"NCT03434041","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-05-25","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":252},{"nctId":"NCT02493868","phase":"PHASE3","title":"A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-10-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":719},{"nctId":"NCT02418585","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-07","conditions":"Treatment-resistant Depression","enrollment":236},{"nctId":"NCT02497287","phase":"PHASE3","title":"A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-09-30","conditions":"Treatment-resistant Depression","enrollment":802},{"nctId":"NCT02422186","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-20","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":139},{"nctId":"NCT03185819","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-10-05","conditions":"Depressive Disorder, Major","enrollment":147},{"nctId":"NCT05268497","phase":"PHASE1","title":"A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression","status":"WITHDRAWN","sponsor":"Janssen Research & Development, LLC","startDate":"2022-09-01","conditions":"Depression","enrollment":""},{"nctId":"NCT04300621","phase":"PHASE1","title":"A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-06-19","conditions":"Healthy","enrollment":16},{"nctId":"NCT03808259","phase":"PHASE1","title":"A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-12-20","conditions":"Healthy","enrollment":96},{"nctId":"NCT03298906","phase":"PHASE1","title":"A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-09-26","conditions":"Healthy","enrollment":16},{"nctId":"NCT04282746","phase":"PHASE1","title":"A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-02-18","conditions":"Healthy","enrollment":17},{"nctId":"NCT03852160","phase":"PHASE3","title":"A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression","status":"WITHDRAWN","sponsor":"Janssen-Cilag International NV","startDate":"2019-12-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":""},{"nctId":"NCT02919579","phase":"PHASE1","title":"A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-10-07","conditions":"Depressive Disorder, Major","enrollment":27},{"nctId":"NCT05565352","phase":"","title":"Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)","status":"ENROLLING_BY_INVITATION","sponsor":"Medical University of Gdansk","startDate":"2022-09-01","conditions":"Major Depressive Disorder, Post Traumatic Stress Disorder, Obsessive-Compulsive Disorder","enrollment":140},{"nctId":"NCT06731647","phase":"PHASE2","title":"Non-steroidal Anti-inflammatory Drugs in Pleurodesis","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-02-01","conditions":"Non-steroidal Anti-inflammatory Drugs, Pleurodesis, Pneumothorax","enrollment":358},{"nctId":"NCT04116528","phase":"PHASE3","title":"Opiate Suicide Study in Patients With Major Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2020-08-01","conditions":"Major Depressive Disorder","enrollment":60},{"nctId":"NCT02651324","phase":"PHASE4","title":"Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis","status":"COMPLETED","sponsor":"Albany Medical College","startDate":"2013-05","conditions":"Idiopathic Scoliosis, Post-operative Pain","enrollment":50},{"nctId":"NCT06735079","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)","status":"WITHDRAWN","sponsor":"MGGM LLC","startDate":"2024-12-27","conditions":"Major Depressive Disorder (MDD)","enrollment":""},{"nctId":"NCT03367533","phase":"PHASE1","title":"Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial","status":"COMPLETED","sponsor":"Yale University","startDate":"2018-11-29","conditions":"Depressive Disorder, Major, Post Traumatic Stress Disorder, Bipolar Disorder","enrollment":13},{"nctId":"NCT05915013","phase":"PHASE1","title":"Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-09-07","conditions":"Depressive Disorder, Major, Post Traumatic Stress Disorder","enrollment":50},{"nctId":"NCT02674295","phase":"PHASE1","title":"A Mass Balance Study With a Microtracer Dose of 14C-esketamine in Healthy Male Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-03","conditions":"Healthy","enrollment":8},{"nctId":"NCT02568176","phase":"PHASE1","title":"Pharmacokinetic Study of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-10","conditions":"Healthy","enrollment":71},{"nctId":"NCT04894864","phase":"PHASE4","title":"Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair","status":"RECRUITING","sponsor":"University of Crete","startDate":"2020-10-08","conditions":"Elective Surgical Procedures, Postoperative Pain, Anesthesia","enrollment":40},{"nctId":"NCT05786066","phase":"PHASE2","title":"The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-04-03","conditions":"Depressive Disorder, Major Depressive Disorder, Bipolar Disorder","enrollment":30},{"nctId":"NCT05940324","phase":"PHASE2","title":"Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)","status":"RECRUITING","sponsor":"Stanford University","startDate":"2024-02-24","conditions":"Obsessive-Compulsive Disorder","enrollment":150},{"nctId":"NCT04119180","phase":"PHASE4","title":"Sedation Versus Protective Stabilization for Pediatric Dental Treatment","status":"RECRUITING","sponsor":"Universidade Federal de Goias","startDate":"2020-01-30","conditions":"Child Behavior, Dental Caries in Children","enrollment":152},{"nctId":"NCT04176419","phase":"PHASE3","title":"Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery","status":"TERMINATED","sponsor":"Case Comprehensive Cancer Center","startDate":"2020-01-17","conditions":"Postoperative Pain Control, Opioid Consumption","enrollment":30},{"nctId":"NCT06660017","phase":"PHASE2","title":"Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse","status":"NOT_YET_RECRUITING","sponsor":"University of Oklahoma","startDate":"2024-11","conditions":"Head and Neck Cancer","enrollment":62},{"nctId":"NCT05156060","phase":"PHASE1, PHASE2","title":"Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer","status":"RECRUITING","sponsor":"Natalie Lockney","startDate":"2022-01-24","conditions":"Head and Neck Cancer, Locally Advanced Head and Neck Carcinoma","enrollment":64},{"nctId":"NCT04820205","phase":"NA","title":"Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Procedural Sedation in Children","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2021-10-29","conditions":"Sedation","enrollment":136},{"nctId":"NCT06566326","phase":"NA","title":"Oropharyngeoesophageal Topical Anesthesia Versus Propofol - Ketamine Sedation for Upper Gastrointestinal Endoscopy","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2023-01-01","conditions":"Upper Gastrointestinal Endoscopy, Topical Anesthesia, Intravenous Sedation","enrollment":60},{"nctId":"NCT04860804","phase":"PHASE4","title":"A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain","status":"COMPLETED","sponsor":"Antonios Likourezos","startDate":"2021-04-22","conditions":"Pain","enrollment":60},{"nctId":"NCT05615948","phase":"PHASE4","title":"Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression","status":"COMPLETED","sponsor":"Maimonides Medical Center","startDate":"2022-12-06","conditions":"Treatment Resistant Depression, Major Depressive Disorder, Analgesia","enrollment":15},{"nctId":"NCT03633058","phase":"PHASE2","title":"A Study to Evaluate Ketamine for the Treatment of Rett Syndrome","status":"COMPLETED","sponsor":"Rett Syndrome Research Trust","startDate":"2019-03-12","conditions":"Rett Syndrome","enrollment":23},{"nctId":"NCT04646694","phase":"PHASE3","title":"The Ketamine for Acute Postoperative Analgesia (KAPA) Trial","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2020-11-17","conditions":"Postoperative Pain","enrollment":40},{"nctId":"NCT04860713","phase":"PHASE4","title":"An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache","status":"COMPLETED","sponsor":"Antonios Likourezos","startDate":"2021-04-22","conditions":"Pain","enrollment":5},{"nctId":"NCT05331131","phase":"PHASE2","title":"Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage Trial","status":"WITHDRAWN","sponsor":"Northwell Health","startDate":"2022-09-19","conditions":"Cancer of Head and Neck, Mucositis Oral, Pharyngeal Mucositis","enrollment":""},{"nctId":"NCT05554627","phase":"PHASE4","title":"VA Aripiprazole vs Esketamine for Treatment Resistant Depression","status":"WITHDRAWN","sponsor":"VA Office of Research and Development","startDate":"2023-10-27","conditions":"Depressive Disorder, Major","enrollment":""},{"nctId":"NCT04822064","phase":"NA","title":"Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Rescue After Failed Pediatric Procedural Sedation","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2022-09-22","conditions":"Sedation","enrollment":70},{"nctId":"NCT04226963","phase":"","title":"A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders","status":"COMPLETED","sponsor":"Medical University of Gdansk","startDate":"2019-12-04","conditions":"Treatment Resistant Depression, Bipolar Depression, Ketamine","enrollment":80},{"nctId":"NCT05925283","phase":"PHASE4","title":"Clinical Study of Oral Midazolam Combined With Esketamine Administered Intranasally for Pediatric Preoperative Sedation","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2023-06-30","conditions":"Anxiety","enrollment":126},{"nctId":"NCT05874245","phase":"PHASE4","title":"Effect of Oral Dexmedetomidine, Ketamine, Or Midazolam as Preioperative Medications.","status":"UNKNOWN","sponsor":"Menoufia University","startDate":"2023-03-01","conditions":"Anesthesia","enrollment":222},{"nctId":"NCT05200806","phase":"PHASE4","title":"A Prospective Pilot Study of a Non-Narcotic Post-Operative Course After Colectomy","status":"UNKNOWN","sponsor":"University of Vermont","startDate":"2022-02-07","conditions":"Analgesia, Post-Operative Pain, Breakthrough Pain","enrollment":25},{"nctId":"NCT04746079","phase":"NA","title":"Positive Imagery Therapy and the Incidence of Emergence Reactions With the Use of Ketamine","status":"UNKNOWN","sponsor":"Mercy Health Ohio","startDate":"2021-02-05","conditions":"Procedural Sedation, Emergence Delirium","enrollment":180},{"nctId":"NCT03751423","phase":"PHASE3","title":"Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion","status":"SUSPENDED","sponsor":"Dr. Marie Eve Sophie Bussiere-Cote","startDate":"2019-06-10","conditions":"Abortion in First Trimester","enrollment":123},{"nctId":"NCT05383313","phase":"PHASE2","title":"Psilocybin Versus Ketamine in Treatment-Resistant Depression","status":"UNKNOWN","sponsor":"National Institute of Mental Health, Czech Republic","startDate":"2021-05-01","conditions":"Treatment Resistant Depression","enrollment":60},{"nctId":"NCT04876066","phase":"PHASE1","title":"Use of Transmucosal Ketamine in Post Stroke Depression","status":"UNKNOWN","sponsor":"West Virginia University","startDate":"2020-11-30","conditions":"Post-stroke Depression","enrollment":21},{"nctId":"NCT01566448","phase":"PHASE2","title":"Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash","status":"COMPLETED","sponsor":"Aaron Cumpston, PharmD, BCOP","startDate":"2012-02","conditions":"Mucositis","enrollment":30},{"nctId":"NCT04702555","phase":"","title":"Analgesic Efficacy of Orally Administered VTS-K for Pain Management","status":"COMPLETED","sponsor":"Antonios Likourezos","startDate":"2021-01-08","conditions":"Pain, Acute","enrollment":25},{"nctId":"NCT00700076","phase":"PHASE1","title":"Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects","status":"COMPLETED","sponsor":"Yale University","startDate":"2008-01-22","conditions":"Healthy","enrollment":15},{"nctId":"NCT04365985","phase":"PHASE2","title":"Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19","status":"TERMINATED","sponsor":"Corewell Health East","startDate":"2020-04-29","conditions":"COVID-19, Acute Respiratory Distress Syndrome, Severe Acute Respiratory Syndrome (SARS)","enrollment":70},{"nctId":"NCT05172739","phase":"PHASE4","title":"Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC","status":"RECRUITING","sponsor":"University of Crete","startDate":"2021-10-01","conditions":"Systemic Inflammatory Response Syndrome, Postoperative Pain, Acute, Postoperative Pain, Chronic","enrollment":70},{"nctId":"NCT05163366","phase":"PHASE3","title":"Oral Morphine Versus Ketamine in Pain Management","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2021-03-01","conditions":"Pain, Procedural","enrollment":44},{"nctId":"NCT02643381","phase":"PHASE4","title":"Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2016-06-06","conditions":"Cardiopulmonary Arrest, Respiratory Arrest","enrollment":801},{"nctId":"NCT03831854","phase":"PHASE3","title":"Lamotrigine in Reducing Psychologic Side-Effect of Perioperative Ketamine","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2019-01-24","conditions":"Reducing Psychological Side Effects of Ketamine","enrollment":46},{"nctId":"NCT02974010","phase":"PHASE2","title":"Sequential Therapy for the Treatment of Severe Bipolar Depression.","status":"COMPLETED","sponsor":"NeuroRx, Inc.","startDate":"2018-01-15","conditions":"Bipolar Depression, Suicidal Ideas, Suicidal Ideation","enrollment":22},{"nctId":"NCT04847245","phase":"NA","title":"Esketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive Disorder","status":"UNKNOWN","sponsor":"Peking University","startDate":"2021-05-01","conditions":"Chronic Visceral Pain, Major Depressive Disorder","enrollment":80},{"nctId":"NCT04156035","phase":"NA","title":"Ketamine-Induced Brain Changes and Their Modulation by Lamotrigine","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2020-03-10","conditions":"Emotions","enrollment":75},{"nctId":"NCT03792672","phase":"PHASE1","title":"A Study to Evaluate Central Nervous System (CNS) Pharmacodynamic Activity of TAK-653 in Healthy Participants Using Transcranial Magnetic Stimulation (TMS)","status":"COMPLETED","sponsor":"Neurocrine Biosciences","startDate":"2019-02-11","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT02341963","phase":"PHASE1","title":"A Pilot Clinical Trial of Oral Ketamine for Acute Pain Management After Amputation Surgery","status":"TERMINATED","sponsor":"Rush University Medical Center","startDate":"2015-01","conditions":"Acute Pain Management, Analgesic, Nonopioid, Amputation of Lower Extremity, All Causes","enrollment":5},{"nctId":"NCT03714919","phase":"PHASE2","title":"A Pilot Study: a Non-opioid Technique for Postoperative Adenoidectomy Pain Relief in Pediatric Patients","status":"COMPLETED","sponsor":"Arlyne Thung","startDate":"2019-08-02","conditions":"Adenoid Hypertrophy","enrollment":10},{"nctId":"NCT04725747","phase":"PHASE4","title":"A Randomized, Double-Masked, Controlled, Single Site Investigator Initiated, Exploratory Study of the Midazolam/Ketamine Melt vs Ketamine Melt Alone vs Midazolam Melt Alone in Subjects Undergoing Intraocular Surgery.","status":"UNKNOWN","sponsor":"Vance Thompson Vision","startDate":"2021-01-25","conditions":"Anesthesia","enrollment":50},{"nctId":"NCT02887404","phase":"NA","title":"Evaluation of Spine Surgery Analgesic Pathway","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2016-07","conditions":"Posterior Spine Surgery","enrollment":299},{"nctId":"NCT02487485","phase":"PHASE2","title":"Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects","status":"COMPLETED","sponsor":"Yale University","startDate":"2016-03","conditions":"Depression","enrollment":23}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":241,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ketamin S, Cristalia, São Paulo, Brazil","Intervention Group","Ketamine","ketamine","ketalar"],"phase":"marketed","status":"active","brandName":"Oral ketamine","genericName":"Oral ketamine","companyName":"Universidade Federal de Goias","companyId":"universidade-federal-de-goias","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ketamine is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor that blocks glutamate signaling in the central nervous system. Used for Treatment-resistant depression (off-label/emerging indication), Chronic pain conditions (off-label), Anesthesia induction and maintenance.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}